The impact of the pneumococcal conjugate vaccine on antimicrobial resistance in the united states since 1996: Evidence for a significant rebound by 2007 in many classes of antibiotics

Microbial Drug Resistance

Volumn 15, Issue 4, 2009, Pages 261-268

  Mera, Robertino M ^a   Miller, Linda A ^a   Amrine Madsen, Heather ^a   Sahm, Daniel F ^b  

^a GLAXOSMITHKLINE   (United States)

^b Eurofins Medinet Inc   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; HUMAN; OTITIS MEDIA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OTITIS MEDIA; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 70350452564     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2009.0056     Document Type: Article

References (28)

1. Bedos, J.P., S. Chevret, C. Chastang, P. Geslin, and B. Regnier. 1996. Epidemiological features and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin. Clin. Infect. Dis. 22: 63-72.
2. Breiman, R.F., J.C. Butler, F.C. Tenover, J.A. Elliot, and R.R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
3. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases, 10th edition. Available at www.cdc.gov= vaccines=pubs=pinkbook, accessed April 13, 2009. Washington, DC: Public Health Foundation, 2002, pp. 257-289. (Online.)
4. Centers for Disease Control and Prevention. 2005. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb. Mortal Wkly. Rep. 54:893-897.
5. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Dagan, R., N. Givon-Lavi, O. Zamir, M. Sikuler-Cohen, L. Guy, J. Janco, P. Yagupski, and D. Fraser. 2002. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J. Infect. Dis. 185:927-936.
7. Farrell, D.J., K.P. Klugman, and M. Pichichero. 2007. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr. Infect. Dis. J. 26:123-128.
8. Fedson, D.S., J.A. Scott, and G. Scott. 1999. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 17:S11-S18.
9. Frazão, N., A. Brito-Avô , C. Simas, J. Saldanha, R. Mato, S. Nunes, N.G. Sousa, J.A. Carriço, J.S. Almeida, I. Santos- Sanches, and H. de Lencastre. 2005. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon. Pediatr. Infect. Dis. J. 24:243-252.
10. Givon-Lavi, N., R. Dagan, D. Fraser, P. Yagupsky, and N. Porat. 1999. Marked differences in pneumococcal carriage and resistance patters between day care centers located in a small area. Clin. Infect. Dis. 29:1274-1280.
11. Hammitt, L.L., D.L. Bruden, J.C. Butler, H.C. Baggett, D.A. Hurlburt, A. Reasonover, and T.W. Hennessy. 2006. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J. Infect. Dis. 193:1487-1494.
12. Hanage, W.P., S.S. Huang, M. Lipsitch, C.J. Bishop, D. Godoy, S.I. Pelton, R. Goldstein, H. Huot, and J.A. Finkelstein. 2007. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J. Infect. Dis. 95:347-352.
13. Hendley, J.O., M.A. Sande, P.M. Stewaret, and J.M. Gwaltney. 1975. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J. Infect. Dis. 132:55-61.
14. Hennessy, T.W., R.J. Singleton, L.R. Bulkow, D.L. Bruden, D.A. Hurlburt, D. Parks, M. Moore, A.J. Parkinson, A. Schuchat, and J.C. Butler. 2005. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine 23:5464-5473.
15. Jacobs, M.R. 1996. Increasing importance of antibioticresistant Streptococcus pneumoniae in acute otitis media. Pediatr. Infect. Dis. J. 15:940-943.
16. Kaplan, S.L., E.O. Mason, E.R. Wald, G.E. Shutze, J.S. Bradley, T.Q. Tan, J.A. Hoffman, L.G. Givner, R. Yogev, and W.J. Barson. 2004. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113:443-449.
17. Kyaw, M.H., R. Lynfield, W. Schaffner, A.S. Craig, J. Hadler, A. Reingold, A.R. Thomas, L.H. Harrison, N.M. Bennett, M.M. Farley, R.R. Facklam, J.H. Jorgensen, J. Besser, E.R. Zell, A. Schuchat, and C.G. Whitney. 2006. Active Bacterial Core Surveillance of the Emerging Infections Program Network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354:1455-1463.
18. Mera, R. 2005. Predicting the future Streptococcus pneumoniae resistance landscape. Curr. Opin. Pharmacol. 5:459-464.
19. Mera, R.M., L.A. Miller, J.J. Daniels, J.G. Weil, and A.R. White. 2005. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diagn. Microbiol. Infect. Dis. 51: 195-200.
20. Mera, R., L.A. Miller, T.R. Fritsche, and R.N. Jones. 2008. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb. Drug Resist. 14:101-107.
21. Mera, R.M., L.A. Miller, and A. White. 2006. Antibacterial use and Streptococcus pneumoniae penicillin resistance: a temporal relationship model. Microb. Drug Resist. 12:158-163.
22. Munoz-Almagro, C., I. Jordan, A. Gene, C. Latorre, J.J. Garcia-Garcia, and R. Pallares. 2008. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin. Infect. Dis. 46: 174-182.
23. Robinson,K.A., W. Baughman,G. Rothrock, N.L. Barrett, M. Pass, C. Lexau, B. Damaske, K. Stefonek, B. Barnes, J. Patterson, E.R. Zell, A. Schuchat, and C.G. Whitney. 2001. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998. Opportunities for prevention in the conjugate vaccine era. JAMA 285:1729-1735.
24. Sá-Leão, R., S. Nunes, A. Brito-Avô , N. Frazão, A.S. Simões, M.I. Crisó stomo, A.C.S. Paulo, J. Saldanha, I. Santos-Sanches, and H. de Lencastre. 2009. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin. Microbiol. Infect. Apr [Epub ahead of print].
25. Stephens, D.S., S.M. Zughaier, C.G. Whitney, W.S. Baughman, L. Barker, K. Gay, D. Jackson, W.A. Orenstein, K. Arnold, A. Schuchat, and M.M. Farley. 2005. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine: populationbased assessment. Lancet 365:855-863.
26. Styers, D., D.J. Sheehan, P. Hogan, and D.F. Sahm. 2006. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann. Clin. Microbiol. Antimicrob. 5:2.
27. Whitney, C.G., M.M. Farley, J. Hadler, L.H. Harrison, C. Lexau, A. Reingold, L. Lefkowitz, P.R. Cieslak, M. Cetron, E.R. Zell, J.H. Jorgensen, A. Schuchat, R.R. Facklam, and N.M. Bennett. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343:1917-1924.
28. Whitney, C.G., M.M. Farley, J. Hadler, L.H. Harrison, N.M. Bennett, R. Lynfield, A. Reingold, P.R. Cieslak, T. Pilishvili, D. Jackson, R.R. Facklam, J.H. Jorgensen, and A. Schuchat. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746. (Pubitemid 36514704)